
India Tightens Oversight as Drugs Controller General of India Targets GLP-1 Misuse
Previous articleViksit Bharat Shiksha Bill Sparks Debate: What It Means for India’s Scientific and Pharma Ecosystem
Next article India Moves Toward Affordable Semaglutide with Dr. Reddy’s Laboratories Approval
Next article India Moves Toward Affordable Semaglutide with Dr. Reddy’s Laboratories Approval